143 related articles for article (PubMed ID: 33496065)
1. The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma.
Pan Y; Zhao S; Chen F
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):445-454. PubMed ID: 33496065
[TBL] [Abstract][Full Text] [Related]
2. Dequalinium chloride inhibits the growth of human glioma cells in vitro and vivo: a study on molecular mechanism and potential targeted agents.
Yu Y; Yang B; Yu J; Zhao G; Chen F
Acta Neurochir (Wien); 2020 Jul; 162(7):1683-1690. PubMed ID: 32410120
[TBL] [Abstract][Full Text] [Related]
3. Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect.
Bae Y; Jung MK; Lee S; Song SJ; Mun JY; Green ES; Han J; Ko KS; Choi JS
Eur J Pharm Biopharm; 2018 Mar; 124():104-115. PubMed ID: 29305141
[TBL] [Abstract][Full Text] [Related]
4. Dequalinium-Derived Nanoconstructs: A Promising Vehicle for Mitochondrial Targeting.
Pawar A; Korake S; Gajbhiye KR
Curr Drug Deliv; 2021; 18(8):1056-1063. PubMed ID: 33475059
[TBL] [Abstract][Full Text] [Related]
5. Selective antimitochondrial agents inhibit calmodulin.
Bodden WL; Palayoor ST; Hait WN
Biochem Biophys Res Commun; 1986 Mar; 135(2):574-82. PubMed ID: 3008727
[TBL] [Abstract][Full Text] [Related]
6. ROS as a novel indicator to predict anticancer drug efficacy.
Zaidieh T; Smith JR; Ball KE; An Q
BMC Cancer; 2019 Dec; 19(1):1224. PubMed ID: 31842863
[TBL] [Abstract][Full Text] [Related]
7. Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain.
Orzáez M; Gortat A; Sancho M; Carbajo RJ; Pineda-Lucena A; Palacios-Rodríguez Y; Pérez-Payá E
Apoptosis; 2011 May; 16(5):460-7. PubMed ID: 21340509
[TBL] [Abstract][Full Text] [Related]
8. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
9. Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death.
Galeano E; Nieto E; García-Pérez AI; Delgado MD; Pinilla M; Sancho P
Leuk Res; 2005 Oct; 29(10):1201-11. PubMed ID: 15893819
[TBL] [Abstract][Full Text] [Related]
10. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.
Weiss MJ; Wong JR; Ha CS; Bleday R; Salem RR; Steele GD; Chen LB
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5444-8. PubMed ID: 3474661
[TBL] [Abstract][Full Text] [Related]
11. Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production.
Sancho P; Galeano E; Nieto E; Delgado MD; García-Pérez AI
Leuk Res; 2007 Jul; 31(7):969-78. PubMed ID: 17250890
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections.
Della Casa V; Noll H; Gonser S; Grob P; Graf F; Pohlig G
Arzneimittelforschung; 2002; 52(9):699-705. PubMed ID: 12404886
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat colon tumor isograft growth with dequalinium chloride.
Bleday R; Weiss MJ; Salem RR; Wilson RE; Chen LB; Steele G
Arch Surg; 1986 Nov; 121(11):1272-5. PubMed ID: 3778199
[TBL] [Abstract][Full Text] [Related]
14. Polyplexes by Polymerized Dequalinium and Bifunctional Aptamer for Mitochondrial Targeting Drug Release to Overcome Drug Resistance.
Gao D; Zhu Q; Ruan J; Sun T; Han L
ACS Appl Bio Mater; 2020 Aug; 3(8):5182-5192. PubMed ID: 35021693
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro evaluation of dequalinium B, a new boron carrier for neutron capture therapy (NCT).
Adams DM; Ji W; Barth RF; Tjarks W
Anticancer Res; 2000; 20(5B):3395-402. PubMed ID: 11131639
[TBL] [Abstract][Full Text] [Related]
16. Medicinal applications and molecular targets of dequalinium chloride.
Bailly C
Biochem Pharmacol; 2021 Apr; 186():114467. PubMed ID: 33577890
[TBL] [Abstract][Full Text] [Related]
17. Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemia.
Pajuelo L; Calviño E; Diez JC; Boyano-Adánez Mdel C; Gil J; Sancho P
Invest New Drugs; 2011 Dec; 29(6):1156-63. PubMed ID: 20524037
[TBL] [Abstract][Full Text] [Related]
18. Persian Gulf Snail Crude Venom (Conus textile): A Potential Source of Anti-Cancer Therapeutic Agents for Glioblastoma through Mitochondrial-Mediated Apoptosis.
Salimi A; Rahimitabar N; Vazirizadeh A; Adhami V; Pourahmad J
Asian Pac J Cancer Prev; 2021 Feb; 22(S1):49-57. PubMed ID: 33576212
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled nanoparticles composed of glycol chitosan-dequalinium for mitochondria-targeted drug delivery.
Mallick S; Song SJ; Bae Y; Choi JS
Int J Biol Macromol; 2019 Jul; 132():451-460. PubMed ID: 30930268
[TBL] [Abstract][Full Text] [Related]
20. Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor.
Newcomb EW; Tamasdan C; Entzminger Y; Alonso J; Friedlander D; Crisan D; Miller DC; Zagzag D
Cell Cycle; 2003; 2(3):243-50. PubMed ID: 12734434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
